U.S. markets closed
  • S&P 500

    4,432.99
    -40.76 (-0.91%)
     
  • Dow 30

    34,584.88
    -166.42 (-0.48%)
     
  • Nasdaq

    15,043.97
    -137.93 (-0.91%)
     
  • Russell 2000

    2,236.87
    +3.96 (+0.18%)
     
  • Crude Oil

    71.96
    -0.01 (-0.01%)
     
  • Gold

    1,753.90
    +2.50 (+0.14%)
     
  • Silver

    22.36
    +0.02 (+0.10%)
     
  • EUR/USD

    1.1737
    -0.0035 (-0.29%)
     
  • 10-Yr Bond

    1.3700
    +0.0390 (+2.93%)
     
  • GBP/USD

    1.3737
    -0.0060 (-0.43%)
     
  • USD/JPY

    109.9190
    +0.2010 (+0.18%)
     
  • BTC-USD

    47,702.99
    -239.37 (-0.50%)
     
  • CMC Crypto 200

    1,193.48
    -32.05 (-2.61%)
     
  • FTSE 100

    6,963.64
    -63.84 (-0.91%)
     
  • Nikkei 225

    30,500.05
    +176.75 (+0.58%)
     

Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claims on Behalf of AdaptHealth Corp. (NASDAQ: AHCO) Investors

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

RADNOR, Pa., July 22, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP is currently investigating potential violations of the federal securities laws on behalf of shareholders of AdaptHealth Corp. ("AdaptHealth") (NASDAQ: AHCO).

KTMC Logo (PRNewsfoto/Kessler Topaz Meltzer & Check, LLP)
KTMC Logo (PRNewsfoto/Kessler Topaz Meltzer & Check, LLP)

On July 19, 2021, Jehoshaphat Research published a short report on AdaptHealth claiming that the company "a roll-up of roll-ups with excessive debt, is deceiving the investor community via its financial reporting practices." The report further stated that "while management claims (and consensus estimates reflect) an organic growth trajectory of 8-10%, AHCO is in fact experiencing double-digit organic decline. It is also, in our opinion, taking steps to obscure that decline which are expressly forbidden by the SEC." AdaptHealth's stock price fell after publication of this report.

If you are an AdaptHealth investor and would like to learn more about our investigation, please contact Kessler Topaz Meltzer & Check, LLP: James Maro, Esq. (484) 270-1453; toll free at (844) 887-9500; via e-mail at info@ktmc.com; or please visit the following link to fill out our online form: https://www.ktmc.com/new-cases/adapthealth-corp-investigation?utm_source=PR&utm_medium=Link&utm_campaign=adapthealth

Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country involving securities fraud, breaches of fiduciary duties and other violations of state and federal law. Kessler Topaz Meltzer & Check, LLP is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world. The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars). For more information about Kessler Topaz Meltzer & Check, LLP, please visit www.ktmc.com.

CONTACT:
Kessler Topaz Meltzer & Check, LLP
James Maro, Jr., Esq.
280 King of Prussia Road
Radnor, PA 19087
(844) 887-9500
info@ktmc.com

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/kessler-topaz-meltzer--check-llp-is-investigating-securities-fraud-claims-on-behalf-of-adapthealth-corp-nasdaq-ahco-investors-301339785.html

SOURCE Kessler Topaz Meltzer & Check, LLP